Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Primarily used to screen for prostate cancer, PSA tests measure the level of prostate-specific antigen in the blood. “The ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

prostate cancer patients frequently report other associated symptoms, e.g., penile length loss, climacturia, or urinary incontinence, which may have a pronounced impact on their quality of life ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

It is performed to address benign conditions causing urinary retention, prostate cancer, or other pelvic cancers. There are two primary types of prostatectomy: simple and radical. A simple ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

AngioDynamics' NanoKnife FDA clearance boosts its potential in cancer treatment. Read why ANGO stock is a buy with its growth ...

After skin cancer, prostate cancer is the most common cancer in men in the US. For the men who have beat prostate cancer once, 20 to 30 percent will show signs of recurrence after the five-year mark ...

Q2 2025 Earnings Call Transcript January 8, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.04, ...